Lv3
310 积分 2025-01-07 加入
Immunogenicity Assays Used in Support of Marketing Applications of Oligonucleotide Therapeutics
1个月前
已完结
Clinical immunology lessons from failed α-Synuclein and Tau immunotherapies: A roadmap for combination strategies in Alzheimer's disease
1个月前
已完结
Donanemab in Early Symptomatic Alzheimer Disease
2个月前
已完结
From Clinical Trials to Memory Clinics, Tau-PET Visual Reads Can Help Diagnosis and Patient Stratification
3个月前
已完结
Plasma pTau217 and Neurofilament Light Chain as Differentiative Markers for Progressive Supranuclear Palsy From Parkinson Disease
6个月前
已完结
Disease course and treatment patterns in progressive supranuclear palsy: A real-world study
6个月前
已关闭
Target product profiles for treatments to delay or prevent symptomatic Alzheimer’s disease
6个月前
已完结
Progressive supranuclear palsy: current approach and challenges to diagnosis and treatment
6个月前
已完结
Alzheimer’s and metabolism wed with IDO1
9个月前
已完结
Restoring hippocampal glucose metabolism rescues cognition across Alzheimer’s disease pathologies
9个月前
已完结
皖公网安备34019202002308
